房颤合并HFpEF患者冷冻球囊消融术后复发预测因素
前瞻性队列研究纳入444例冷冻球囊消融的房颤患者,按是否合并HFpEF分组并行1∶2倾向性评分匹配,207例进入分析。随访292(135,574)d,40例复发;早发房性心律失常和游离三碘甲腺原氨水平是复发影响因素,HFpEF不是。
要点
- 早发房性心律失常与冷冻球囊消融术后房颤复发独立相关(HR=3.586)。
- 游离三碘甲腺原氨水平与术后复发独立相关(HR=0.661)。
- HFpEF不是冷冻球囊消融术后房颤复发的独立影响因素(HR=0.845)。
核心结论
- 冷冻球囊消融术可作为房颤合并HFpEF患者有效的治疗方案。
- 早发房性心律失常与游离三碘甲腺原氨水平是冷冻球囊消融术后房颤复发的影响因素。
研究设计与样本
- 前瞻性队列研究,连续纳入2020年5月至2023年12月于天津医科大学第二医院心脏内科行冷冻球囊消融术的房颤患者。
- 共纳入444例患者,年龄(67±9)岁,男性221例(49.8%);非HFpEF组371例,HFpEF组73例。
- 采用倾向性评分匹配按1∶2匹配基线数据,207例进入后续分析,年龄(68±10)岁,男性101例(48.8%),非HFpEF组138例,HFpEF组69例。
主要发现
- 随访292(135,574)d,207例中40例房颤复发,167例未复发。
- 复发组早发房性心律失常发生率高于非复发组(40.0%比10.2%,P<0.001)。
- 复发组左心耳最大排空速度低于非复发组[47.00(25.00,65.00)cm/s比54.00(38.00,70.74)cm/s,P=0.030]。
- 单因素Cox分析显示HFpEF不是复发影响因素(HR=0.845,95%CI 0.429~1.662,P=0.625)。
- 多因素Cox分析显示早发房性心律失常(HR=3.586,95%CI 1.680~7.651,P=0.001)和游离三碘甲腺原氨水平(HR=0.661,95%CI 0.479~0.911,P=0.011)是复发影响因素。
临床怎么用
- 对房颤合并HFpEF患者,冷冻球囊消融可作为有效治疗选择。
- 术后应关注早发房性心律失常,其与复发风险升高相关。
- 游离三碘甲腺原氨水平较低者复发风险可能更高,可作为风险分层参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the efficacy of cryoballoon ablation in the treatment of patients with atrial fibrillation (AF) complicated by heart failure with preserved ejection fraction (HFpEF), and to analyze the relevant influencing factors of AF recurrence after cryoballoon ablation. Methods: This prospective cohort study consecutively enrolled patients with AF who underwent cryoballoon ablation in the Department of Cardiology, Second Hospital of Tianjin Medical University between May 2020 and December 2023. According to the presence or absence of HFpEF, the enrolled patients were divided into non-HFpEF group and HFpEF group, and their baseline data were collected. Propensity score matching was used to match the baseline data of the two groups at a ratio of 1∶2. In the matched cohort, patients were followed up, and further divided into recurrence group and non-recurrence group based on whether AF recurrence occurred during the follow-up period. Cox regression model was used to analyze the influencing factors of AF recurrence after cryoballoon ablation. Results: A total of 444 patients were enrolled, aged (67±9) years, including 221 (49.8%) males; among them, 371 were in the non-HFpEF group and 73 in the HFpEF group. After propensity score matching, 207 patients were included in the subsequent analysis, aged (68±10) years, consisting of 101(48.8%) males. 138 patients were in the non-HFpEF group and 69 in the HFpEF group. During a follow-up period of 292 (135, 574) days, 40 patients had AF recurrence, while 167 had no recurrence. Compared with the non-recurrence group, the recurrence group had a higher incidence of early atrial arrhythmia (40.0% vs. 10.2%, P<0.001) and a lower maximum emptying velocity of the left atrial appendage (47.00 (25.00, 65.00) cm/s vs. 54.00 (38.00, 70.74) cm/s, P=0.030). Univariate Cox regression analysis showed that HFpEF (HR=0.845, 95%CI 0.429-1.662, P=0.625) was not an influencing factor for AF recurrence after cryoballoon ablation. Multivariate Cox regression analysis revealed that early atrial arrhythmia (HR=3.586, 95%CI 1.680-7.651, P=0.001) and free triiodothyronine level (HR=0.661, 95%CI 0.479-0.911, P=0.011) were influencing factors for AF recurrence after cryoballoon ablation. Conclusion: Cryoballoon ablation can be used as an effective treatment option for patients with AF complicated by HFpEF. Early atrial arrhythmia and free triiodothyronine levels were influencing factors of AF recurrence after cryoballoon ablation. 目的: 探讨冷冻球囊消融术治疗心房颤动(房颤)合并射血分数保留型心力衰竭(HFpEF)患者的有效性,并分析冷冻球囊消融术后房颤复发的相关影响因素。 方法: 本研究为前瞻性队列研究。收集2020年5月至2023年12月于天津医科大学第二医院心脏内科行冷冻球囊消融术的房颤患者。根据是否合并HFpEF将纳入患者分为非HFpEF组和HFpEF组,收集患者基线资料。采用倾向性评分匹配,对2组患者的基线数据进行1∶2匹配。在匹配队列中,对患者进行随访,根据随访期间是否出现房颤复发,进一步将患者分为复发组和非复发组。采用Cox比例风险回归模型分析冷冻球囊消融术后房颤复发的影响因素。 结果: 共纳入444例房颤患者,年龄(67±9)岁,男性221例(49.8%),非HFpEF组371例,HFpEF组73例。经倾向性评得分匹配后207例患者纳入后续分析,年龄(68±10)岁,男性101例(48.8%),非HFpEF组138例,HFpEF组69例。随访292(135,574)d,40例患者房颤复发,167例患者未复发。与非复发组相比,复发组患者早发房性心律失常发生率更高(40.0%比10.2%,P<0.001),左心耳最大排空速度更低[47.00(25.00,65.00)cm/s比54.00(38.00,70.74)cm/s,P=0.030]。单因素Cox比例风险回归模型分析显示,HFpEF(HR=0.845,95%CI 0.429~1.662,P=0.625)不是冷冻球囊消融术后房颤复发的影响因素。多因素Cox比例风险回归模型分析显示,早发房性心律失常(HR=3.586,95%CI 1.680~7.651,P=0.001)和游离三碘甲腺原氨水平(HR=0.661,95%CI 0.479~0.911,P=0.011)是冷冻球囊消融术后房颤复发的影响因素。 结论: 冷冻球囊消融术可作为房颤合并HFpEF患者有效的治疗方案。早发房性心律失常与游离三碘甲腺原氨水平是冷冻球囊消融术后房颤复发的影响因素。.
引用
- Song WH, Wang Q, Shangguan WF, et al. [Predictors of recurrence for patients with atrial fibrillation and heart failure with preserved ejection fraction after cryoablation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 41529848. doi:10.3760/cma.j.cn112148-20251103-00774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。